Studies have revealed a high level of IL-6 expression in the tumors and blood of ESCC patients and induce the infiltration of CD39 natural killer cells, which is connected to an unfavorable prognosis for those individuals [39]. This evidence concerns the gene ENTPD1 and esophageal squamous cell carcinoma.